RELL CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. RELL Gen Silencer sind erhältlich als RELL CRISPR/Cas9 Knockout Plasmide und RELL Double Nickase Plasmide. RELL CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
RELL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RELL1 CRISPR/Cas9 KO Plasmid (h) | sc-416200 | h | Gene Knockout | GFP | 0 | ||
RELL1 HDR Plasmid (h) | sc-416200-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RELL1 Double Nickase Plasmid (h) | sc-416200-NIC | h | Gene Knockout | Puromycin | 0 | ||
RELL1 Double Nickase Plasmid (h2) | sc-416200-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RELL1 CRISPR/Cas9 KO Plasmid (m) | sc-430322 | m | Gene Knockout | GFP | 0 | ||
RELL1 HDR Plasmid (m) | sc-430322-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RELL1 Double Nickase Plasmid (m) | sc-430322-NIC | m | Gene Knockout | Puromycin | 0 | ||
RELL1 Double Nickase Plasmid (m2) | sc-430322-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
RELL2 CRISPR/Cas9 KO Plasmid (h) | sc-415434 | h | Gene Knockout | GFP | 0 | ||
RELL2 HDR Plasmid (h) | sc-415434-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
RELL2 Double Nickase Plasmid (h) | sc-415434-NIC | h | Gene Knockout | Puromycin | 0 | ||
RELL2 Double Nickase Plasmid (h2) | sc-415434-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
RELL2 CRISPR/Cas9 KO Plasmid (m) | sc-432539 | m | Gene Knockout | GFP | 0 | ||
RELL2 HDR Plasmid (m) | sc-432539-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
RELL2 Double Nickase Plasmid (m) | sc-432539-NIC | m | Gene Knockout | Puromycin | 0 | ||
RELL2 Double Nickase Plasmid (m2) | sc-432539-NIC-2 | m | Gene Knockout | Puromycin | 0 |
RELL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
RELL1 CRISPR Activation Plasmid (h) | sc-416200-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL1 CRISPR Activation Plasmid (h2) | sc-416200-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL1 Lentiviral Activation Particles (h) | sc-416200-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL1 Lentiviral Activation Particles (h2) | sc-416200-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL1 CRISPR Activation Plasmid (m) | sc-430322-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL1 CRISPR Activation Plasmid (m2) | sc-430322-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL1 Lentiviral Activation Particles (m) | sc-430322-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL1 Lentiviral Activation Particles (m2) | sc-430322-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL2 CRISPR Activation Plasmid (h) | sc-415434-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL2 CRISPR Activation Plasmid (h2) | sc-415434-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL2 Lentiviral Activation Particles (h) | sc-415434-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL2 Lentiviral Activation Particles (h2) | sc-415434-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL2 CRISPR Activation Plasmid (m) | sc-432539-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL2 CRISPR Activation Plasmid (m2) | sc-432539-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL2 Lentiviral Activation Particles (m) | sc-432539-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
RELL2 Lentiviral Activation Particles (m2) | sc-432539-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |